RecruitingNCT06434337

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Sponsor

M.D. Anderson Cancer Center

Enrollment

600 participants

Start Date

Jul 23, 2024

Study Type

OBSERVATIONAL

Conditions

Human Papillomavirus

Summary

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

Eligibility

Sex: FEMALEMin Age: 21 Years

Inclusion Criteria4

People with a cervix 21 years of age or older.
Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
Willing and able to provide informed consent.
Able to perform protocol-required activities. Able to speak and read English or Spanish.

Exclusion Criteria3

Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
Participant or provider decision not to collect a sample for this study.
Participants that are pregnant.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.